Skip to content

Ceredex Value Advisors LLC: EQIX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Ceredex Value Advisors LLC on EQIX, newest first. How the timeline and the estimate are built.

Ceredex Value Advisors LLC held 18,416 EQIX shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 18,416 shares
    Change vs previous 13F -29,455 shares

    0.54% of the 13F portfolio, value $19,196,655.

    13F-HR 0001738726-26-000006 filed by Ceredex Value Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 47,871 shares
    Change vs previous 13F +16,696 shares

    1.48% of the 13F portfolio, value $46,925,069.

    13F-HR 0001738726-26-000004 filed by Ceredex Value Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 31,175 shares
    Change vs previous 13F +2,375 shares

    0.72% of the 13F portfolio, value $23,885,038.

    13F-HR 0001738726-26-000002 filed by Ceredex Value Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F/A 28,800 shares
    Change vs previous 13F -4,225 shares

    0.52% of the 13F portfolio, value $22,557,312.

    13F-HR/A 0001628280-25-052325 filed by Ceredex Value Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 33,025 shares
    Change vs previous 13F not available

    0.56% of the 13F portfolio, value $26,270,397.

    13F-HR 0001587281-25-000003 filed by Ceredex Value Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).